The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Dupouy, Sandra ^a   Viardot Foucault, Véronique ^a,b   Alifano, Marco ^b   Souazé, Frédérique ^a   Plu Bureau, Geneviève ^b   Chaouat, Marc ^c   Lavaur, Anne ^b   Hugol, Danielle ^b   Gespach, Christian ^a   Gompel, Anne ^a,b   Forgez, Patricia ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL ROTHSCHILD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; TAMOXIFEN; UNCLASSIFIED DRUG; ESTRADIOL;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; AGED; BIOPSY; BREAST TUMOR; CANCER INVASION; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTORS, NEUROTENSIN;

EID: 64149121622     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004223     Document Type: Article

References (30)

1. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34: 405-412.
2. Reinecke M (1985) Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Prog Histochem Cytochem 16: 1-172.
3. Baca I, Feurle GE, Schwab A, Mittmann U, Knauf W, et al. (1982) Effect of neurotensin on exocrine pancreatic secretion in dogs. Digestion 23: 174-183.
4. Andersson S, Rosell S, Hjelmquist U, Chang D, Folkers K (1977) Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand 100: 231-235.
5. Armstrong MJ, Parker MC, Ferris CF, Leeman SE (1986) Neurotensin stimulates [3H]oleic acid translocation across rat small intestine. Am J Physiol 251: G823-G829.
6. Evers BM (2006) Neurotensin and growth of normal and neoplastic tissues. Peptides 27: 2424-2433.
7. Souaze F, Dupouy S, Viardot-Foucault V, Bruyneel E, Attoub S, et al. (2006) Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression. Cancer Res 66: 6243-6249.
8. Somai S, Gompel A, Rostene W, Forgez P (2002) Neurotensin counteracts apoptosis in breast cancer cells. Biochem Biophys Res Commun 295: 482-488.
9. Kapuscinski M, Shulkes A, Read D, Hardy KJ (1990) Expression of neurotensin in endocrine tumors. J Clin Endocrinol Metab 70: 100-106.
10. Dong Z, Wang X, Zhao Q, Townsend CM Jr, Evers BM (1998) DNA methylation contributes to expression of the human neurotensin/neuromedin N gene. Am J Physiol 274: G535-G543.
11. Vita N, Laurent P, Lefort S, Chalon P, Dumont X, et al. (1993) Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett 317: 139-142.
12. Zhao D, Kuhnt-Moore S, Zeng H, Wu JS, Moyer MP, et al. (2003) Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol 284: C1397-C1404.
13. Leyton J, Garcia-Marin L, Jensen RT, Moody TW (2002) Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells. Eur J Pharmacol 442: 179-186.
14. Ehlers RA, Zhang Y, Hellmich MR, Evers BM (2000) Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2. Biochem Biophys Res Commun 269: 704-708.
15. Wang Q, Zhou Y, Evers BM (2006) Neurotensin phosphorylates GSK-3alpha/ beta through the activation of PKC in human colon cancer cells. Neoplasia 8: 781-787.
16. Watters JJ, Dorsa DM (1998) Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci 18: 6672-6680.
17. Alexander MJ, Leeman SE (1994) Estrogen-inducible neurotensin immunoreactivity in the preoptic area of the female rat. J Comp Neurol 345: 496-509.
18. Alexander MJ (1993) Estrogen-regulated synthesis of neurotensin in neurosecretory cells of the hypothalamic arcuate nucleus in the female rat. Endocrinology 133: 1809-1816.
19. Toy-Miou-Leong M, Cortes CL, Beaudet A, Rostene W, Forgez P (2004) Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation. J Biol Chem 279: 12636-12646.
20. Ginestier C, Cervera N, Finetti P, Esteyries S, Esterni B, et al. (2006) Prognosis and gene expression profiling of 20q13-amplified breast cancers. Clin Cancer Res 12: 4533-4544.
21. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272.
22. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
23. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5: 607-616.
24. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, et al. (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362: 362-369.
25. Souaze F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, et al. (2006) Neurotensin receptor 1 gene activation by the Tcf/ {beta}-catenin pathway is an early event in human colonic adenomas. carcinogenesis 27: 708-716.
26. Rostene WH, Alexander MJ (1997) Neurotensin and neuroendocrine regulation. Front Neuroendocrinol 18: 115-173.
27. Hassan S, Dobner PR, Carraway RE (2004) Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. Regul Pept 120: 155-166.
28. Zhao D, Zhan Y, Koon HW, Zeng H, Keates S, et al. (2004) Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem 279: 43547-43554.
29. Gompel A, Malet C, Spritzer P, Lalardrie JP, Kuttenn F, et al. (1986) Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63: 1174-1180.
30. Souaze F, Rostene W, Forgez P (1997) Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms. J Biol Chem 272: 10087-10094.